ADVENTRX Pharmaceuticals (ANX) Posts Q1 EPS Loss of 13c
Get Alerts ANX Hot Sheet
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q1 EPS of ($0.13), $0.13 better than the analyst estimate of ($0.26).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- CVB Financial (CVBF) Tops Q1 EPS by 1c
- Alamos Gold (AGI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!